49 results
8-K
EX-99.1
PASG
Passage Bio Inc
4 Mar 24
Passage Bio Reports Fourth Quarter and Full-year 2023 Financial Results and Provides Recent Business Highlights
7:02am
served as the company’s Senior Vice President, Finance and Interim CFO and brings 25 years of pharmaceutical and biotech strategic financial leadership
8-K
EX-99.2
PASG
Passage Bio Inc
4 Mar 24
Passage Bio Reports Fourth Quarter and Full-year 2023 Financial Results and Provides Recent Business Highlights
7:02am
passagebio.com | NASDAQ: PASG
27 Demonstrated Leadership LEADERSHIP TEAM Deep experience in rare disease, CNS disorders and genetic medicines Eden Fucci SVP
8-K
PASG
Passage Bio Inc
4 Mar 24
Passage Bio Reports Fourth Quarter and Full-year 2023 Financial Results and Provides Recent Business Highlights
7:02am
2023, Ms. Borthwick served as our Vice President of Finance. From June 1997 to October 2021, Ms. Borthwick served in various leadership roles
8-K
EX-99.1
172px
5 Jan 24
Regulation FD Disclosure
4:05pm
8-K
EX-99.2
k2yt5h
13 Nov 23
Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights
7:00am
8-K
wi4u3k83
20 Jul 23
Departure of Directors or Certain Officers
7:00am
8-K
EX-99.2
fl7vf
11 May 23
Passage Bio Reports First Quarter 2023 Financial Results and Provides Recent Business Highlights
7:09am
PRE 14A
4nvq1ogykn
3 Apr 23
Preliminary proxy
4:05pm
8-K
03k0pbe
6 Jul 22
Departure of Directors or Certain Officers
7:00am